16 | Temozolomide (Temodar)FDA LinkGeneric
11/2023
-
02/2008 |
7 | Biomarkers (Surrogate Marker)IBA
04/2024
-
12/2017 |
4 | Bevacizumab (Avastin)FDA Link
10/2022
-
01/2015 |
3 | Atorvastatin (Lipitor)FDA Link
04/2024
-
09/2022 |
2 | Donepezil (Aricept)FDA LinkGeneric
05/2024
-
01/2019 |
2 | Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
04/2024
-
09/2022 |
2 | RNA (Ribonucleic Acid)IBA
07/2023
-
01/2018 |
2 | Proteins (Proteins, Gene)FDA Link
07/2023
-
06/2015 |
2 | Doxorubicin (Adriamycin)FDA LinkGeneric
06/2023
-
09/2022 |
2 | LactoferrinIBA
03/2022
-
09/2018 |
2 | theasinensin AIBA
03/2022
-
09/2018 |
2 | ErbB Receptors (EGF Receptor)IBA
06/2020
-
02/2008 |
2 | PT2385IBA
01/2020
-
01/2018 |
2 | VaccinesIBA
10/2019
-
02/2008 |
2 | Influenza Vaccines (Influenza Vaccine)FDA Link
08/2018
-
12/2014 |
2 | Transcription Factors (Transcription Factor)IBA
01/2018
-
01/2018 |
2 | Vitamin EFDA LinkGeneric
01/2018
-
03/2013 |
2 | VorinostatFDA Link
01/2018
-
06/2015 |
2 | coenzyme Q10 (CoQ10)IBA
01/2018
-
03/2013 |
2 | Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2018
-
01/2017 |
2 | Tyrosine Kinase InhibitorsIBA
01/2017
-
02/2008 |
2 | Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
12/2012
-
12/2004 |
1 | Nootropic Agents (Nootropics)IBA
05/2024 |
1 | salicylhydroxamic acid (SHAM)IBA
05/2024 |
1 | Antihypertensive Agents (Antihypertensives)IBA
04/2024 |
1 | AnthracyclinesIBA
04/2024 |
1 | GossypolIBA
01/2024 |
1 | gossypol acetic acidIBA
01/2024 |
1 | Enzyme Inhibitors (Inhibitors, Enzyme)IBA
11/2023 |
1 | veliparibIBA
11/2023 |
1 | Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
11/2023 |
1 | Membrane Proteins (Integral Membrane Proteins)IBA
07/2023 |
1 | AntibodiesIBA
07/2023 |
1 | cobimetinibIBA
07/2023 |
1 | Creatine Kinase (Creatine Phosphokinase)IBA
07/2023 |
1 | VemurafenibIBA
07/2023 |
1 | Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
07/2023 |
1 | HhAntag691IBA
09/2022 |
1 | Antineoplastic Agents (Antineoplastics)IBA
10/2021 |
1 | B7-H1 AntigenIBA
10/2021 |
1 | Peptides (Polypeptides)IBA
10/2021 |
1 | Immune Checkpoint InhibitorsIBA
10/2021 |
1 | APOBEC-1 DeaminaseIBA
10/2021 |
1 | pembrolizumabIBA
10/2021 |
1 | atezolizumabIBA
10/2021 |
1 | Topotecan (Hycamtin)FDA LinkGeneric
03/2021 |
1 | Topoisomerase InhibitorsIBA
03/2021 |
1 | 2,2- dimethyl- N- (6- oxo- 6,7- dihydro- 5H- dibenzo(b,d)azepin- 7- yl)- N'- (2,2,3,3,3- pentafluoropropyl)malonamideIBA
01/2021 |
1 | EnzymesIBA
01/2021 |
1 | epidermal growth factor receptor VIIIIBA
06/2020 |
1 | osimertinibIBA
06/2020 |
1 | endothelial PAS domain-containing protein 1IBA
01/2020 |
1 | taxaneIBA
01/2020 |